Loading organizations...
Loading organizations...
Neuron Venture Partners is an active investment firm specializing in venture capital and private equity. Based in San Francisco, California, the firm strategically engages with early-stage companies to foster innovation and growth. Its operational model involves a focused team, typically consisting of 2 to 10 employees, enabling a hands-on approach to its investment portfolio.
The firm's investment strategy includes participating in significant funding rounds for technology companies. An example of this is its involvement in the $45.8 million seed round for Poetiq, an AI meta-system developer. This participation highlights Neuron Venture Partners' role in supporting advancements in artificial intelligence and other high-growth sectors, alongside other notable venture capital and operator collective firms.
Key people at Neuron Venture Partners.
Yes, Neuron Venture Partners was an investor in the $45.8 million seed round for Poetiq, an AI meta-system developer. This investment highlights their support for technology-driven ventures.
Yes, Neuron Venture Partners was an investor in the $45.8 million seed round for Poetiq, an AI meta-system developer. This investment highlights their support for technology-driven ventures.
Key people at Neuron Venture Partners.
Neuron Venture Partners operates as an investment firm with a primary focus on the venture capital and private equity landscape. The organization maintains an active status within the broader financial ecosystem, dedicating its resources to identifying and supporting promising ventures. Its strategic involvement aims to contribute to the development and scaling of companies across various high-growth industries.
The firm's headquarters are situated in San Francisco, California, United States. This location places Neuron Venture Partners within one of the world's leading technology and innovation hubs, providing access to a dynamic network of startups, entrepreneurs, and co-investors. The firm operates with a compact team, typically ranging from two to ten employees, which allows for a concentrated and agile approach to its investment decisions and portfolio management.
Neuron Venture Partners actively participates in funding rounds for emerging technology companies. A notable instance of its investment activity is its involvement in the seed funding round for Poetiq, an AI meta-system developer. This particular round successfully secured $45.8 million, underscoring the firm's commitment to supporting advancements in artificial intelligence and related technological fields.
In the Poetiq seed round, Neuron Venture Partners joined a syndicate of investors that included FYRFLY Venture Partners, Capital, Operator Collective, and Hico Ventures. This collaborative investment approach demonstrates the firm's engagement within the venture capital community, often partnering with other specialized funds to provide comprehensive support and capital to its portfolio companies.
Through its strategic investments, Neuron Venture Partners aims to play a role in fostering innovation and driving the growth of next-generation companies. Its focus on early-stage funding, particularly in sectors like AI, positions the firm as a contributor to the evolving technological landscape, helping to bring new solutions and platforms to market.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2026 | Oryon Cell Therapies | $21.0M Series A Extension | — | Byers Capital, Neuron.VC |
| Jan 30, 2026 | Poetiq | $45.8M Seed | FYRFLY Venture Partners, Surface Ventures, Philipp Stauffer | 468 Capital, Hico Ventures, Operator Collective, Y Combinator, Y Combinator |
